AMCo Ireland
AMCo is the result of a merger of Amdipharm and the Mercury Pharma Group in 2013, and is an emerging pharmaceutical enterprise comprising a series of companies operating internationally.
Amdipharm was formed in 2002 and specialises in marketing internationally branded products to primary and secondary care prescribers. Since 2002 and through twelve acquisitions, Amdipharm now offers 35 products which sell in over 100 countries across the world.
Financial Data
-
31st Dec 19 Source: CRO
- €282.6 million turnover
-
€6.6 million
profit - 16 employees
-
31st Dec 18 Source: CRO
- €221.3 million turnover
-
€5 million
profit - 14 employees
- 8 more years available »
Ranking
By Turnover
(€282.6 million)- 258th in Top Companies
- 32nd in Pharma
- 34th in Retailing
By Employees
(16)- 974th in Top Companies
- 79th in Pharma
- 162nd in Retailing
-
- 16
- €282.6 million
Employees
- Madeleine Donnelly Director
Latest News
- 1:10pm Brexit boosts Ireland’s international banking sector
- 12:54pm Shannon Group to spend €4m on property redevelopment
- 12:54pm Central issue in Johnny Ronan versus DigitalBridge still outstanding
- 12:43pm Irish-born entrepreneur Mike Lynch to learn verdict of $5bn fraud suit
- 12:27pm Big preference for remote working post restrictions, CSO survey finds